Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Feature-weighted maximum representative subsampling.

Scientific reports·2026

Same author

Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever Virus.

Vaccines·2026

Same author

Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria.

Journal of nephrology·2026

Same author

Beyond sequence similarity: ML-powered identification of pHLA off-targets for TCR-mimic antibodies using high throughput binding kinetics.

mAbs·2025

Same author

Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patterns.

Rheumatology international·2025

Same author

Echocardiographic measures read by artificial intelligence enable accurate and rapid prediction of the worsening of heart failure.

European heart journal. Digital health·2025

Same journal

Unified heterogeneity-aware benchmark of drug synergy prediction: a cross-study analysis of traditional machine learning and graph deep learning models.

Journal of cheminformatics·2026

Same journal

Count your bits: fingerprint benchmarking to assess broad chemical space representation.

Journal of cheminformatics·2026

Same journal

Sampling out-of-distribution chemical spaces via Bayesian flow.

Journal of cheminformatics·2026

Same journal

Hold on tight: the kinetic profiling of opioid receptor ligands using the CORAL-MD.

Journal of cheminformatics·2026

Same journal

Transformer-accelerated discovery of inhibitors targeting the RpsA<sub>Δ438</sub> deletion in PZA-resistant tuberculosis.

Journal of cheminformatics·2026

Same journal

DICL: a manually curated database of ion channels and ligands as a useful platform for drug discovery targeting ion channels.

Journal of cheminformatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 4, 2026

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

Improving structural similarity based virtual screening using background knowledge.

Tobias Girschick, Lucia Puchbauer, Stefan Kramer¹

¹Johannes Gutenberg-Universität Mainz, Institut für Informatik, Staudingerweg 9, 55128 Mainz, Germany. kramer@informatik.uni-mainz.de.

Journal of Cheminformatics

|December 18, 2013

Summary

This summary is machine-generated.

Enhancing virtual screening with binding-relevant knowledge significantly improves compound prioritization. Automated data mining methods offer a competitive alternative to manual selection, crucial for drug discovery when receptor information is limited.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

Related Experiment Videos

Last Updated: May 4, 2026

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

Area of Science:

Computational Chemistry
Cheminformatics
Drug Discovery

Background:

Virtual screening uses similarity rankings to prioritize compounds in early drug discovery.
Structural similarity measures are common but can lack performance in specific applications.
Integrating binding-relevant background knowledge enhances similarity ranking quality.

Purpose of the Study:

To link ranking-based virtual screening with fragment-based data mining.
To demonstrate improved similarity rankings by incorporating binding-relevant background knowledge.

Main Methods:

Extending structural similarity measures with binding-relevant substructures.
Utilizing both hand-selected and data mining-derived background knowledge.
Performing virtual screening experiments to evaluate ranking performance.

Main Results:

Both approaches (hand-selected and data mining-derived knowledge) significantly improved enrichment factors in virtual screening.
Data mining methods provided competitive results compared to hand-selected knowledge.

Conclusions:

Adding binding-relevant background knowledge substantially improves virtual screening similarity rankings.
Automated data mining approaches make manual selection less critical, aiding drug discovery without receptor data.